We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
FN1 is potential prognostic, high expression is unfavorable in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
287.8
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
2974.2
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
2561.5
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
1955.7
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1845.3
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1827.4
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
1778.5
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
1725.0
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
1701.5
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
1689.7
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
1676.2
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1669.2
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1620.9
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
1500.8
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1445.6
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
1287.2
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
1257.0
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
1226.7
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
1213.9
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
1204.5
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
1191.3
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1137.3
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
1099.9
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
1095.7
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
1093.2
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
1084.6
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1067.9
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
1014.7
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
975.6
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
969.7
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
927.6
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
924.0
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
908.4
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
903.7
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
863.2
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
852.8
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
849.3
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
843.5
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
826.4
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
816.0
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
784.5
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
779.1
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
766.5
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
764.3
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
761.0
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
760.1
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
710.4
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
696.6
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
658.7
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
653.7
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
607.6
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
600.9
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
600.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
599.5
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
581.0
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
558.6
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
534.8
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
522.6
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
521.3
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
521.1
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
496.6
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
488.4
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
455.5
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
451.6
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
448.4
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
446.8
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
442.4
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
442.0
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
441.3
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
438.8
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
437.3
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
437.2
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
422.9
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
421.2
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
409.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
401.8
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
396.8
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
395.2
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
388.9
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
383.4
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
376.9
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
366.5
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
364.9
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
354.5
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
350.1
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
346.9
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
346.0
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
343.0
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
335.3
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
327.9
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
325.0
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
320.8
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
317.1
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
314.7
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
311.8
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
310.5
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
309.9
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
294.1
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
288.5
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
277.7
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
273.4
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
264.7
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
263.2
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
249.7
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
248.2
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
245.3
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
236.0
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
234.9
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
232.2
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
228.1
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
227.9
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
220.9
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
217.8
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
216.2
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
213.0
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
211.7
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
209.3
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
203.5
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
200.3
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
196.5
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
195.8
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
195.4
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
193.9
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
193.3
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
188.2
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
187.7
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
181.6
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
179.4
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
179.0
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
177.3
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
175.6
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
175.3
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
170.7
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
169.9
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
169.3
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
167.1
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
165.3
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
161.4
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
160.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
159.9
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
158.1
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
151.7
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
150.7
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
148.6
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
148.3
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
147.8
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
146.5
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
145.7
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
143.1
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
142.0
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
140.5
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
139.2
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
137.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
136.2
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
134.2
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
130.9
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
130.5
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
130.0
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
129.6
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
127.6
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
124.7
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
122.0
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
119.4
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
119.2
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
119.1
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
117.3
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
115.4
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
115.1
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
114.9
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
114.0
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
112.3
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
109.8
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
109.5
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
107.4
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
107.2
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
106.9
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
106.8
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
106.4
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
104.4
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
104.2
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
104.0
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
102.8
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
101.0
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
100.6
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
99.1
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
98.1
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
97.8
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
97.3
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
97.1
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
94.8
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
94.7
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
93.8
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
93.2
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
90.3
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
90.1
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
87.3
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
86.8
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
86.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
86.4
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
86.0
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
85.8
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
85.7
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
84.7
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
81.5
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
80.2
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
80.2
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
79.9
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
78.9
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
75.4
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
74.2
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
74.1
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
73.8
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
73.7
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
72.9
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
72.4
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
71.9
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
71.1
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
70.0
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
68.9
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
68.4
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
68.0
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
67.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
67.2
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
65.6
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
65.5
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
64.4
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
64.1
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
63.0
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
61.7
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
61.0
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
60.8
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
59.5
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
59.5
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
59.1
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
58.7
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
57.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
57.0
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
56.6
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
55.6
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
55.6
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
55.0
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
54.6
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
54.5
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
51.6
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
50.1
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
49.9
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
48.7
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
48.2
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
48.0
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
48.0
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
46.4
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
45.9
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
45.4
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
44.7
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
44.4
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
44.2
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
44.1
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
42.7
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
40.8
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
40.2
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
39.7
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
37.7
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
37.4
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
36.9
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
36.8
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
36.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
36.0
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
35.8
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
35.7
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
34.8
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
34.7
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
34.7
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
34.6
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
34.6
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
34.0
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
33.5
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
33.1
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
33.0
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
32.7
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
31.8
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
30.8
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
30.7
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
30.1
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
29.8
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
29.4
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
28.5
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
28.1
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
27.8
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
26.9
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
26.7
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
26.7
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
25.5
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
23.6
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
23.3
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
22.2
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
22.1
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
21.8
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
21.4
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
21.4
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
20.6
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
20.4
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
20.3
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
20.2
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
19.5
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
19.1
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
18.6
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
18.3
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
17.4
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
17.4
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
17.2
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
16.7
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
16.1
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
15.6
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
15.5
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
15.5
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
15.4
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
15.3
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
15.2
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
15.0
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
14.6
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
14.5
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
14.5
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
13.7
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
13.0
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
12.8
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
12.5
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
12.0
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
11.5
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
11.2
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
11.1
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
10.8
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
10.6
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
10.1
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
10.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
9.7
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
9.6
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
9.5
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
8.6
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
8.4
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
8.1
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
7.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
7.6
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
7.2
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
7.1
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
6.9
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
6.3
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
5.2
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
4.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2.9
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
FN1 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
511.4
Number of samples
81
Samples
Sample
Description
TPM
DO46402
0 years, female, NA, stage:III, dead, 511 days
2407.4
DO46348
0 years, female, NA, stage:IV, dead, 287 days
2171.2
DO46327
0 years, female, NA, stage:III, dead, 184 days
1990.3
DO46508
0 years, female, NA, stage:III, dead, 2101 days
1920.7
DO46332
0 years, female, NA, stage:III, dead, 689 days
1907.9
DO46382
0 years, female, NA, stage:IV, dead, 311 days
1838.4
DO46432
0 years, female, NA, stage:III, alive, 2218 days
1381.2
DO46453
0 years, female, NA, stage:III, dead, 3294 days
1351.2
DO46398
0 years, female, NA, stage:III, alive, 437 days
1192.9
DO46354
0 years, female, NA, stage:III, dead, 843 days
1132.2
DO46448
0 years, female, NA, stage:III, dead, 654 days
1092.9
DO46358
0 years, female, NA, stage:III, dead, 423 days
1054.8
DO46392
0 years, female, NA, stage:III, dead, 628 days
1020.2
DO46560
0 years, female, NA, stage:IV, dead, 286 days
954.7
DO46528
0 years, female, NA, stage:III, alive, 6139 days
910.8
DO46597
0 years, female, NA, stage:III, dead, 393 days
890.3
DO46376
0 years, female, NA, stage:III, dead, 1430 days
829.2
DO46364
0 years, female, NA, stage:III, dead, 806 days
827.1
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
807.1
DO46340
0 years, female, NA, stage:III, dead, 616 days
798.5
DO46388
0 years, female, NA, stage:III, dead, 413 days
786.5
DO46551
0 years, female, NA, stage:III, dead, 1055 days
764.9
DO46374
0 years, female, NA, stage:III, dead, 1409 days
764.5
DO46568
0 years, female, NA, stage:III, dead, 320 days
658.2
DO46571
0 years, female, NA, stage:III, dead, 243 days
644.4
DO46336
0 years, female, NA, stage:IV, dead, 664 days
638.4
DO46334
0 years, female, NA, stage:III, dead, 496 days
636.8
DO46346
0 years, female, NA, stage:III, dead, 1187 days
532.1
DO46325
0 years, female, NA, stage:III, dead, 477 days
523.1
DO46561
0 years, female, NA, stage:III, dead, 195 days
510.0
DO46326
0 years, female, NA, stage:III, dead, 701 days
497.6
DO46368
0 years, female, NA, stage:III, dead, 2879 days
497.4
DO46344
0 years, female, NA, stage:III, dead, 642 days
496.6
DO46566
0 years, female, NA, stage:III, dead, 673 days
455.9
DO46443
0 years, female, NA, stage:III, dead, 2464 days
454.4
DO46386
0 years, female, NA, stage:III, dead, 1162 days
388.9
DO46468
0 years, female, NA, stage:III, alive, 2776 days
351.5
DO46408
0 years, female, NA, stage:III, dead, 489 days
349.7
DO46463
0 years, female, NA, stage:III, dead, 2451 days
340.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
331.6
DO46412
0 years, female, NA, stage:III, dead, 597 days
327.9
DO46380
0 years, female, NA, stage:III, dead, 1423 days
297.1
DO46591
0 years, female, NA, stage:III, dead, 195 days
242.4
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
239.5
DO46350
0 years, female, NA, stage:III, dead, 886 days
239.5
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
218.0
DO46378
0 years, female, NA, stage:III, alive, 843 days
203.8
DO46493
0 years, female, NA, stage:IV, alive, 839 days
199.5
DO46602
0 years, female, NA, stage:III, dead, 205 days
181.7
DO46384
0 years, female, NA, stage:III, dead, 614 days
167.1
DO46362
0 years, female, NA, stage:III, dead, 1639 days
155.7
DO46330
0 years, female, NA, stage:III, dead, 684 days
150.5
DO46372
0 years, female, NA, stage:III, dead, 1326 days
136.7
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
130.2
DO46533
0 years, female, NA, stage:III, alive, 3667 days
121.6
DO46329
0 years, female, NA, stage:III, dead, 1699 days
102.1
DO46338
0 years, female, NA, stage:III, dead, 596 days
98.5
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
98.2
DO46576
0 years, female, NA, stage:III, alive, 133 days
83.0
DO46342
0 years, female, NA, stage:III, dead, 1398 days
81.1
DO46606
0 years, female, NA, stage:III, alive, 804 days
79.1
DO46538
0 years, female, NA, stage:III, dead, 1527 days
75.0
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
67.7
DO46356
0 years, female, NA, stage:III, dead, 911 days
64.7
DO46400
0 years, female, NA, stage:III, dead, 719 days
62.9
DO46586
0 years, female, NA, stage:III, dead, 1019 days
54.7
DO46352
0 years, female, NA, stage:III, dead, 677 days
48.7
DO46588
0 years, female, NA, stage:III, dead, 438 days
47.0
DO46370
0 years, female, NA, stage:III, dead, 1727 days
45.2
DO46331
0 years, female, NA, stage:III, dead, 612 days
40.9
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
39.3
DO46366
0 years, female, NA, stage:III, dead, 2054 days
37.0
DO46333
0 years, female, NA, stage:III, dead, 359 days
32.6
DO46404
0 years, female, NA, stage:III, dead, 690 days
29.7
DO46546
0 years, female, NA, stage:III, dead, 1889 days
29.6
DO46328
0 years, female, NA, stage:III, dead, 972 days
21.5
DO46390
0 years, female, NA, stage:III, dead, 374 days
20.0
DO46581
0 years, female, NA, stage:III, dead, 408 days
19.4
DO46396
0 years, female, NA, stage:III, dead, 583 days
14.6
DO46518
0 years, female, NA, stage:III, alive, 2960 days
11.8
DO46611
0 years, female, NA, stage:III, dead, 734 days
7.8
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
2.6
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
1.7
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
1.6
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
1.6
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
1.5
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.5
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
1.4
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
1.2
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
1.2
15524912-685a-47ce-a824-567848_D2
Tumor
1.2
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
1.2
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
1.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
1.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.1
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
1.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
1.0
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
1.0
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
1.0
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
1.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
1.0
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
1.0
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.9
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.9
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.9
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.8
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.8
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.8
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.7
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.7
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.6
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.6
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.6
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.6
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.5
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.5
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.5
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.5
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.5
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.4
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.3
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.3
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.3
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.3
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.2
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.2
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.1
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.1
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.1
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.1
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.0
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.0
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.0
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.0
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.0
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.0
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.0
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.0
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.1
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.1
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.1
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.1
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.2
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.2
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.3
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.3
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.3
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.4
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.5
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.5
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.5
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.5
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.6
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.6
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.6
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.7
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.7
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.7
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.8
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.8
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.8
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.8
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.8
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.9
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.9
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.9
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-1.0
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-1.0
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-1.0
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-1.0
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-1.1
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-1.1
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-1.1
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-1.4
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.